跳至主要内容
临床试验/IRCT2016030626935N1
IRCT2016030626935N1已完成未知

Depression and pain improvement in patients with fibromyalgia syndrome with duloxetin or pregsbalin: a comparative open labeled study

Vice Chancellor for Research of Iran University of Medical Sciences0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
Female

入选标准

  • fibromyalgia patients; age between 18 to 65;
  • Exclusion criteria: receiving Duloxetine, Pregabalin and Gabapentin with other antidepressants during the 12 weeks before entering the study; pregnancy or have a plan to become pregnant during the study; underlying rheumatic disease, cancer, and other diseases that can cause chronic pain which has not been defined in the fibromyalgia syndrome; having a job or duties which need high concentration or alertness; use of MAOI (monoamine oxidase inhibitors) within 14 days before study; chronic liver disease, severe renal failure and uncontrolled narrow-angle glaucoma; history of hypersensitivity to Pregabalin and its components

排除标准

  • 未提供

研究者

发起方
Vice Chancellor for Research of Iran University of Medical Sciences

相似试验